Petition · past parliament · Department of Health and Social Care
Provide funding to make bevacizumab and biosimilars available on NHS
Closed
2,561 signatures
What the petition asks
The UK is behind most first world countries in routinely using bevacizumab or biosimilars to treat many cancers. Recent 2019 evidence shows that survival rates are better for MCRC patients using this treatment alongside chemotherapy.
People may be dying unnecessarily due to this drug not being available.
We believe the Government should review the decision not to make bevacizumab and biosimilars routinely available for the treatment of certain cancers to take into account changes in the medical understanding of Metastatic Colorectal Cancer in particular and the use of targeted (EGFR) therapies.
We believe the Government should review the decision not to make bevacizumab and biosimilars routinely available for the treatment of certain cancers to take into account changes in the medical understanding of Metastatic Colorectal Cancer in particular and the use of targeted (EGFR) therapies.
Timeline
| 8 Oct 2020 | Petition opened for signatures |
| 8 Apr 2021 | Closed to new signatures |
Key facts
Signatures
2,561
Status
Closed
Department
Department of Health and Social Care
Opened
8 Oct 2020
Closed
8 Apr 2021
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 15 Jul 2026.